GMED

$87.50

Public overview and default valuation.

Log in to track this stock.

Valuation Details
Default assumptions: 10Y forecast, 9% market return, 2.5% terminal growth, 8.43% trendline growth.
Want to create your own valuation? Create a free account.
$138.15

With 20% Margin of Safety (MoS):

$110.52
26.31% upside
Capital Efficiency
Average Quarterly ROIC
2.6%
Cost of Capital (estimated)7%
Value StatusUnderperforming Capital

The company is earning below its required return. This may indicate inefficient use of capital or excess cash that isn't being reinvested.

Complete historical ROIC is available with
.
Fundamental Score
76
BullishWeighted across 6 signals
DCF Discount
26.3% discount to price
94
FCF Yield
7.3% trailing FCF yield
100
ROIC vs WACC
ROIC 2.6% vs WACC 7.0% (0.4x)
19
Net Debt / FCF
Net cash position
100
Buybacks
Share count shrinking
80
FCF CAGR (5Y)
28.5% 5Y FCF CAGR
100
Strengths: DCF Discount, FCF Yield. Concerns: ROIC vs WACC.
Narrative Score
59
Weak
Weighted across 5 recent drivers · Last 30 days-1 vs previousVs 6-Month Baseline: High (83th pct)
Trend: StableConfidence: 76%Updated: 3h ago
Sources: 27 (News 19 · Analyst 8)
Drivers
5 regulatory scrutiny+0.5
13 news sentiment+0.2
Analyst upgrades+0.2
Earnings beat+0.1
7 analyst reiterations0.0
Other Metrics
P/E27.8
Profit Margin15.3%
Owner Earnings$835.43m
One Dollar Premise0.00%
Debt/Equity0.18
Current Ratio3.54
PEG1.455
Free Cash Flow (in millions)
2009201020112012201320142015201620172018201920202021202220232024
$58$84$99$101$117$104$173$213$211$241$243$262$333$253$322$851
How Intrinziq Estimates Fair Value

Intrinziq estimates Globus Medical, Inc.'s intrinsic value using a discounted cash flow (DCF) model based on free cash flow trends and a market-based discount rate. The model projects future cash flows over ten years and discounts them using a market return assumption to estimate fair value.

Globus Medical, Inc.Healthcare

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, it distributes human cell, tissue, and cellular and tissue-based products. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

Last updated: Feb 06, 2026
Data sources: Financial Modeling Prep
This valuation is based on assumptions and publicly available data. It is not financial advice or a recommendation to buy or sell any security. Always do your own research before making investment decisions.